Paulo Vilar Saavedra,
Clinical Associate Professor, Medical Oncology Service Chief
Department:
Small Animal Clinical Sciences
Business Phone:
(352) 392-2235
Business Email:
pvilarsaavedra@ufl.edu
About Paulo Vilar Saavedra
Dr. Vilar Saavedra received his D.V.M. from the University of Santiago de Compostela (USC). He continued his postgraduate education with an M.S degree from The Ohio State University, and later, a Ph.D. degree from the USC. Dr. Vilar completed his Medical Oncology Residency at Michigan State University (MSU) & Virginia Tech. Dr Vilar and is board-certified by the American College of Internal Medicine (Oncology Specialty), and he has been acting as professor (MSU 2014 -2021) since then.
His clinical interests include Comparative Oncology – Clinical Trials, Paraneoplastic Hemostatic Disorders, Target Therapy – Immunotherapy, and Individualized Therapy.
In his free time, he enjoys outdoors and team sports (soccer – basketball).
Accomplishments
Fellowship – USA
2008
·
"Barrie de La Maza" Foundation
Fellowship Graduate Studies
2005
·
"La Caixa" Foundation
Teaching Profile
Courses Taught
2021-2024
VEM5872C Veterinary Medical & Radiation Oncology Clerkship
2022-2024
VEM5308 Vet Med Oncology
Board Certifications
-
OncologyACVIM
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0001-8381-180X
Areas of Interest
- Clinical Trials Design & Analysis
- Cancer Thrombosis
- Comparative Oncology
- Hematology and Oncology
Publications
2024
Septic Peritonitis Secondary to Neoplasia in Two Canine Cancer-Bearing Patients Lacking Gastrointestinal and Hepatic Organ Rupture.
Journal of the American Animal Hospital Association.
60(1):20-24
[DOI] 10.5326/JAAHA-MS-7379.
[PMID] 38175981.
2022
Case report: MicroRNA-10b as a therapeutic target in feline metastatic mammary carcinoma and its implications for human clinical trials.
Frontiers in oncology.
12
[DOI] 10.3389/fonc.2022.959630.
[PMID] 36387245.
2021
Chemoenzymatic Synthesis of 9NHAc-GD2 Antigen to Overcome the Hydrolytic Instability of O-Acetylated-GD2 for Anticancer Conjugate Vaccine Development.
Angewandte Chemie (International ed. in English).
60(45):24179-24188
[DOI] 10.1002/anie.202108610.
[PMID] 34469031.
2020
Neoplastic melanocytic pleural effusion in a Portuguese water dog
Veterinary Clinical Pathology.
49(4):652-654
[DOI] 10.1111/vcp.12919.
2020
Outcome of a dog undergoing definitive‐intent intensity‐modulated radiation therapy for an intranasal ganglioneuroma
Veterinary Radiology & Ultrasound.
61(5)
[DOI] 10.1111/vru.12877.
2019
Clinical characteristics and outcome of dogs with presumed primary renal lymphoma
Journal of Small Animal Practice.
60(11):663-670
[DOI] 10.1111/jsap.13059.
2019
Imaging and histopathological characteristics of carcinoma‐induced bone formation in skeletal muscle
Veterinary Record Case Reports.
7(1)
[DOI] 10.1136/vetreccr-2018-000739.
2018
A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studies.
BMC cancer.
18(1)
[DOI] 10.1186/s12885-018-4132-0.
[PMID] 29490634.
2018
Tonsillar plasmacytoma in a dog.
The Canadian veterinary journal = La revue veterinaire canadienne.
59(8):851-854
[PMID] 30104774.
2017
Abstract 3921: Detection of circulating tumor cells in osteosarcoma: A validation study using a translational model
Tumor Biology.
[DOI] 10.1158/1538-7445.am2017-3921.
2017
Skin depigmentation associated with toceranib phosphate in a dog
Veterinary Dermatology.
28(4):400-e95
[DOI] 10.1111/vde.12422.
2016
Prostate cancer characterization by optical contrast enhanced photoacoustics
Photons Plus Ultrasound: Imaging and Sensing 2016.
[DOI] 10.1117/12.2213064.
[PMID] 28529403.
2014
Clinical, Morphological, and Molecular Characterization of Penicillium canis sp. nov., Isolated from a Dog with Osteomyelitis
Journal of Clinical Microbiology.
52(7):2447-2453
[DOI] 10.1128/jcm.03602-13.
2012
Expression of the Bcl-2 apoptotic marker in cats diagnosed with inflammatory bowel disease and gastrointestinal lymphoma
Journal of Feline Medicine and Surgery.
14(10):741-745
[DOI] 10.1177/1098612×12451404.
2012
Morphopathological features of a severe ulcerative disease outbreak associated with Tenacibaculum maritimum in cultivated sole, Solea senegalensis (L.)
Journal of Fish Diseases.
35(6):437-445
[DOI] 10.1111/j.1365-2761.2012.01360.x.
2012
Retrospective evaluation of the effectiveness of epsilon aminocaproic acid for the prevention of postamputation bleeding in retired racing Greyhounds with appendicular bone tumors: 46 cases (2003-2008)
Journal of Veterinary Emergency and Critical Care.
22(3):332-340
[DOI] 10.1111/j.1476-4431.2012.00735.x.
2011
Hemostatic abnormalities in dogs with carcinoma: a thromboelastographic characterization of hypercoagulability.
Veterinary journal (London, England : 1997).
190(2):e78-e83
[DOI] 10.1016/j.tvjl.2011.02.025.
[PMID] 21454111.
2011
Thromboelastographic changes after gonadectomy in retired racing greyhounds
Veterinary Record.
169(4):99-99
[DOI] 10.1136/vr.d2671.
[PMID] 21724753.
2011
Thromboelastographic profile for a dog with hypocoagulable and hyperfibrinolytic phase of disseminated intravascular coagulopathy
Journal of Small Animal Practice.
52(12):656-659
[DOI] 10.1111/j.1748-5827.2011.01139.x.
2011
Thromboelastography in healthy, sick non-septic and septic neonatal foals
Australian Veterinary Journal.
89(12):500-505
[DOI] 10.1111/j.1751-0813.2011.00854.x.
2010
Thromboelastography in healthy horses and horses with inflammatory gastrointestinal disorders and suspected coagulopathies
Journal of Veterinary Emergency and Critical Care.
20(5):488-493
[DOI] 10.1111/j.1476-4431.2010.00576.x.
2008
Effects of Time of Collection and Sample Processing on von Willebrand Factor Concentration in Retired Racing Greyhounds
Journal of Veterinary Internal Medicine.
22(6):1447-1448
[DOI] 10.1111/j.1939-1676.2008.0198.x.
2008
Thromboelastographic Tracings in Retired Racing Greyhounds and in Non-Greyhound Dogs
Journal of Veterinary Internal Medicine.
22(2):374-379
[DOI] 10.1111/j.1939-1676.2008.0061.x.
Grants
Sep 2023
ACTIVE
Phase II open-label non-randomized multicenter clinical trial of trametinib for dogs with histiocytic sarcoma
Role: Co-Investigator
Funding: MICHIGAN STATE UNIV
via MORRIS ANIMAL FOU
Mar 2022
ACTIVE
A GD3 nano-scaled liposomal cancer vaccine for canine hemangiosarcoma
Role: Co-Project Director/Principal Investigator
Funding: AMER KENNEL CLUB CANINE HLTH FOU
Education
PhD
2020
·
University of Santiago de Compostela
MSc
2008
·
The Ohio State University
DVM
2004
·
University of Santiago de Compostela
Contact Details
Phones:
- Business:
- (352) 392-2235
Emails:
- Business:
- pvilarsaavedra@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100126
GAINESVILLE FL 32610